These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12608936)

  • 21. Factors influencing the desire for long-term growth hormone replacement in adults.
    Holmes SJ; Shalet SM
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):151-7. PubMed ID: 7554309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study.
    Vahl N; Juul A; Jørgensen JO; Orskov H; Skakkebaek NE; Christiansen JS
    J Clin Endocrinol Metab; 2000 May; 85(5):1874-81. PubMed ID: 10843168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
    Bülow B; Link K; Ahrén B; Nilsson AS; Erfurth EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):683-91. PubMed ID: 15579181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
    Yuen KC; Dunger DB
    Clin Endocrinol (Oxf); 2006 May; 64(5):549-55. PubMed ID: 16649975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term growth hormone replacement therapy in hypopituitary adults.
    Verhelst J; Abs R
    Drugs; 2002; 62(16):2399-412. PubMed ID: 12396230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.
    Carroll PV; Littlewood R; Weissberger AJ; Bogalho P; McGauley G; Sönksen PH; Russell-Jones DL
    Eur J Endocrinol; 1997 Aug; 137(2):146-53. PubMed ID: 9272102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two years of replacement therapy in adults with growth hormone deficiency.
    Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults.
    Johannsson G; Rosén T; Bengtsson BA
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):571-81. PubMed ID: 9425397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C; Johannsson G; Bengtsson BA; Svensson J
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.
    Florkowski CM; Collier GR; Zimmet PZ; Livesey JH; Espiner EA; Donald RA
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):769-73. PubMed ID: 9039344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects.
    Malik IA; Foy P; Wallymahmed M; Wilding JP; MacFarlane IA
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):75-81. PubMed ID: 12807507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.
    Li Voon Chong JS; Groves T; Foy P; Wallymahmed ME; MacFarlane IA
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):175-81. PubMed ID: 11874408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
    Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.